Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective? - PubMed (original) (raw)

Editorial

Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Phillip A Low et al. Ann Neurol. 2012 Jul.

Free article

No abstract available

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources